SurfaceWise2
Commercial- Indications
- Surface disinfection, COVID-19 prevention
Company intelligence / Profile preview
Allied BioScience developed proprietary antimicrobial coatings such as SurfaceWise2 that were marketed as providing continuous protection against viruses and bacteria on treated surfaces. The company received emergency EPA authorization during the COVID‑19 pandemic but later faced regulatory action over product claims. Independent studies showed efficacy against several pathogens; however, EPA testing raised concerns about real-world performance under certain conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Allied BioScience.